Sun Pharmaceutical (India) Performance
| SUNPHARMA | 1,781 46.65 2.69% |
The entity has a beta of -0.17, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Sun Pharmaceutical are expected to decrease at a much lower rate. During the bear market, Sun Pharmaceutical is likely to outperform the market. At this point, Sun Pharmaceutical has a negative expected return of -0.0246%. Please make sure to validate Sun Pharmaceutical's treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Sun Pharmaceutical performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Sun Pharmaceutical Industries has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Sun Pharmaceutical is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors. ...more
Forward Dividend Yield 0.0076 | Payout Ratio 0.2901 | Last Split Factor 2:1 | Forward Dividend Rate 13.5 | Ex Dividend Date 2024-07-12 |
1 | Brokerage Radar UBS favors Sun Pharma, Cipla Morgan Stanley sees relief for IT sector - Moneycontrol | 09/26/2024 |
2 | Sun Pharmaceutical Industries Stocks Live Updates Sun Pharmas Price Drop, A Temporary Setback Amidst Mo... - The Economic Times | 09/30/2024 |
3 | Sun Pharma Share Price Highlights Sun Pharma Stock Price History - The Economic Times | 10/08/2024 |
4 | Volumes jump at Sun Pharma Advanced Research Company Ltd counter - Business Standard | 11/22/2024 |
| Begin Period Cash Flow | 46.2 B |
Sun |
Sun Pharmaceutical Relative Risk vs. Return Landscape
If you would invest 181,595 in Sun Pharmaceutical Industries on September 2, 2024 and sell it today you would lose (3,505) from holding Sun Pharmaceutical Industries or give up 1.93% of portfolio value over 90 days. Sun Pharmaceutical Industries is generating negative expected returns and assumes 1.1315% volatility on return distribution over the 90 days horizon. Simply put, 10% of stocks are less volatile than Sun, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Sun Pharmaceutical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sun Pharmaceutical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Sun Pharmaceutical Industries, and traders can use it to determine the average amount a Sun Pharmaceutical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0218
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SUNPHARMA |
Estimated Market Risk
| 1.13 actual daily | 10 90% of assets are more volatile |
Expected Return
| -0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Sun Pharmaceutical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sun Pharmaceutical by adding Sun Pharmaceutical to a well-diversified portfolio.
Sun Pharmaceutical Fundamentals Growth
Sun Stock prices reflect investors' perceptions of the future prospects and financial health of Sun Pharmaceutical, and Sun Pharmaceutical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Sun Stock performance.
| Return On Equity | 0.17 | ||||
| Return On Asset | 0.0854 | ||||
| Profit Margin | 0.22 % | ||||
| Operating Margin | 0.24 % | ||||
| Current Valuation | 4.09 T | ||||
| Shares Outstanding | 2.4 B | ||||
| Price To Book | 6.18 X | ||||
| Price To Sales | 8.49 X | ||||
| Revenue | 477.58 B | ||||
| Gross Profit | 332.24 B | ||||
| EBITDA | 138.36 B | ||||
| Net Income | 95.76 B | ||||
| Cash And Equivalents | 13.87 B | ||||
| Total Debt | 32.74 B | ||||
| Book Value Per Share | 288.72 X | ||||
| Cash Flow From Operations | 121.35 B | ||||
| Earnings Per Share | 46.13 X | ||||
| Total Asset | 854.63 B | ||||
| Retained Earnings | 501.55 B | ||||
About Sun Pharmaceutical Performance
Assessing Sun Pharmaceutical's fundamental ratios provides investors with valuable insights into Sun Pharmaceutical's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Sun Pharmaceutical is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Sun Pharmaceutical is entity of India. It is traded as Stock on NSE exchange.Things to note about Sun Pharmaceutical performance evaluation
Checking the ongoing alerts about Sun Pharmaceutical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Sun Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Sun Pharmaceutical generated a negative expected return over the last 90 days | |
| Sun Pharmaceutical is unlikely to experience financial distress in the next 2 years | |
| About 55.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Volumes jump at Sun Pharma Advanced Research Company Ltd counter - Business Standard |
- Analyzing Sun Pharmaceutical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Sun Pharmaceutical's stock is overvalued or undervalued compared to its peers.
- Examining Sun Pharmaceutical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Sun Pharmaceutical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Sun Pharmaceutical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Sun Pharmaceutical's stock. These opinions can provide insight into Sun Pharmaceutical's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Sun Stock Analysis
When running Sun Pharmaceutical's price analysis, check to measure Sun Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sun Pharmaceutical is operating at the current time. Most of Sun Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Sun Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sun Pharmaceutical's price. Additionally, you may evaluate how the addition of Sun Pharmaceutical to your portfolios can decrease your overall portfolio volatility.